Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivo

Medicine & Life Sciences

• N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine 100%
• Adenocarcinoma of Lung 67%
• ErbB Receptors 60%
• Mutation 35%
• Vascular Endothelial Growth Factor Receptor-2 23%
• Protein-Tyrosine Kinases 17%
• Heterografts 11%
• In Vitro Techniques 8%
• Angiogenesis Inhibitors 7%
• Non-Small Cell Lung Carcinoma 5%
• Transfection 5%
• Clinical Trials 4%
• Cell Line 3%
• Growth 3%
• Neoplasms 2%